Invesco Pharmaceuticals ETF Rating $113.85 0.00 (0.00%) As of 06/12/2026 04:10 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Invesco Pharmaceuticals ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PJP Aggregate RatingModerate Buy 2.69Holdings in PJP have an aggregate rating of Moderate Buy based on 423 analyst ratings issued in the past year covering 25 companies (92.0% of the portfolio).PJP Aggregate Price Target$113.85High Prediction$113.85Average Prediction$113.85Low Prediction$113.85Holdings in PJP have an aggregate price target of $113.85 and a range of $113.85 to $113.85 covering 25 companies (92.0% of the portfolio).PJP Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy0 Buy rating(s)Moderate Buy19 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Pharmaceuticals ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 PJP Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.67%CORTCorcept Therapeutics$82.913.8467 of 5 stars2.75$88.83 7.1%8Positive News5.36%LLYEli Lilly and Company$1,137.01+0.4%4.1125 of 5 stars2.87$1,227.74 8.0%30Trending NewsAnalyst RevisionGap Up4.94%ABBVAbbVie$227.54-0.1%4.4846 of 5 stars2.88$253.43 11.4%25Trending News4.94%PFEPfizer$26.19-0.1%3.8629 of 5 stars2.25$28.82 10.1%20Trending NewsAnalyst Downgrade4.89%MRKMerck & Co., Inc.$119.05+0.0%4.468 of 5 stars2.68$128.18 7.7%19Trending NewsOptions VolumeGap Up4.77%LQDALiquidia$71.232.7932 of 5 stars2.90$60.29 -15.4%10Insider Trade4.75%JNJJohnson & Johnson$240.57-0.1%4.417 of 5 stars2.74$253.04 5.2%27Trending NewsInsider Trade4.53%GILDGilead Sciences$125.594.9211 of 5 stars2.86$156.93 25.0%29Trending NewsAnalyst Revision4.49%AMGNAmgen$355.203.8196 of 5 stars2.48$354.12 -0.3%31Trending NewsAnalyst Forecast4.04%TVTXTravere Therapeutics$52.041.4535 of 5 stars2.69$50.17 -3.6%13Analyst ForecastGap Down3.98%ABTAbbott Laboratories$87.89-0.3%4.9846 of 5 stars2.88$118.38 34.7%26Trending NewsDividend AnnouncementAnalyst ForecastAnalyst Revision3.78%JAZZJazz Pharmaceuticals$230.563.3405 of 5 stars2.84$246.06 6.7%19Trending NewsInsider Trade3.57%LGNDLigand Pharmaceuticals$255.542.4415 of 5 stars2.88$257.71 0.9%8Insider Trade3.31%UTHRUnited Therapeutics$545.964.2269 of 5 stars2.85$619.42 13.5%13Insider Trade3.18%HRMYHarmony Biosciences$34.464.4951 of 5 stars2.27$40.89 18.7%11Gap Up2.84%VTRSViatris$16.483.2458 of 5 stars2.43$17.50 6.2%7News CoveragePositive News2.83%ANIPANI Pharmaceuticals$81.684.1513 of 5 stars2.63$107.33 31.4%82.81%BIIBBiogen$200.053.5817 of 5 stars2.55$217.26 8.6%292.69%OCULOcular Therapeutix$8.942.9335 of 5 stars2.79$23.78 166.0%14Gap Down2.65%INVAInnoviva$22.744.0229 of 5 stars2.57$36.20 59.2%72.57%BMYBristol Myers Squibb$57.05-0.1%4.7238 of 5 stars2.37$61.31 7.5%19Trending News2.51%AMRXAmneal Pharmaceuticals$16.202.3522 of 5 stars2.71$15.80 -2.5%7Analyst Downgrade2.40%SUPNSupernus Pharmaceuticals$44.413.4241 of 5 stars2.43$62.17 40.0%7Gap Up2.26%REGNRegeneron Pharmaceuticals$612.144.8595 of 5 stars2.70$792.65 29.5%27Positive News2.22%TARSTarsus Pharmaceuticals$61.953.528 of 5 stars2.78$90.67 46.4%9News CoveragePositive News This page (NYSEARCA:PJP) was last updated on 6/15/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredIs SpaceX really worth 1.78 Trillion?With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...InvestPub | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredSpaceX is chump change compared to Elon’s $20T ‘iPhone’Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredThe roadshow starts Monday. This stock isn't ready.The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...Behind the Markets | SponsoredTrump just signed itA recent policy development is drawing attention from income-focused investors. According to one analyst, c...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PJP Stock Alerts